I suspect we should get near some news or update pretty...

I suspect we should get near some news or update pretty soon!Good luck everyone Cheers ! Dom . About apricitabine (ATC)

ATC is currently in a Phase III clinical trial in HIV patients with NRTI resistance. Dr. Jonathan Coates, Avexa’s Chief Scientific Offer, is a former Project Leader for multiple anti-viral programs at GlaxoSmithKline and a co-inventor of anti-viral drug 3TC, one of the best selling anti-HIV drugs in history with over USD $8 billion in global sales to date. ATC targets a current unmet medical need that has earned the compound Fast Track status with the U.S. Food and Drug Administration. More than 130 sites have been initiated for ATC’s Phase III trial with initial 16 week data results expected in June 2009.